***Background.*** In recent guidelines, trough serum concentraions of ≥ 15 µg/mL are recommended for vancomycin in severe infections by less-susceptible staphylococcal species such as MRSA. However, optimal doses to attain the trough value in febrile neutropenic (FN) patients are not yet well established.

***Methods.*** To evaluate the influence of neutropenia on the pharmacokinetics and dosage requirements of vancomycin, the trough levels in 8 patients (Goup C; age 59.0 ± 9.1) without neutropenia (≥ 1,000/μL) were compared with those in 7 patients (Group B; age 61.3 ± 12.6) with mild (100 - 1,000/ μL) or in 8 patients (Group A; age 58.5 ± 9.2) with severe (\<100/μL) febrile neutropenia using a two-compartment Bayesian pharmacokinetic program. All patients received 2g/day of vancomycin for more than 2 days. Only patients with estimate creatinine clearance (eCCr) more than 70 mL/minute were included in the study.

***Results.*** Increased total clearance and the shorter elimination-half life of vancomycin was observed in patients with neutropenia compared with non-neutropenic patients, and thus, serum vancomycin concentration (SVC) was significantly lower in neutropenic patients \[Group A 9.6 ± 1.7, Group B 10.8 ± 2.6, Group C 14.7 ± 1.3, p \< 0.01\]. Severely neutropenic patients in particular required a higher vancomycin dosage regimen compared with the non-neutropenic patients \[Group A 62.2 ±12.5 mg/kg/day vs Group C 40.0 ± 8.1 mg/kg/day, p = 0.007\] to attain trough SVC of 15 mg/mL. Significant inverse association was observed between SVC and eCCr in neutropenic, but not in non-neutropenic patients \[Group A (p = 0.006), Group B (p = 0.041), Group C patients (p = 0.610)\].

***Conclusion.*** Higher initial doses considering the degree of neutropenia and eCCr, and careful monitoring of the serum concentraions thereafter are required for vancomycin in patients with febrile neutropenia.
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